Study site visit - First LEXO® pediatric research

Last week, our Research Coordinator, Iris Jakob, and our Area Sales Manager, Clara Silvestro, traveled to Genova to meet the research team of IRCCS Ospedale Pediatrico Giannina Gaslini. The clinic is conducting a study on robot-assisted gait rehabilitation in children with neurological disabilities – the very first one worldwide with LEXO® in children.

Many studies demonstrate the benefits of robot-assisted rehabilitation in children with neurological disabilities in terms of distance traveled, walking speed, endurance, and balance. However, it is necessary to increase the number of trials to achieve greater homogeneity between protocols to define the number of sessions required, their frequency, and repeatability over time (Castelli et al. 2022).

The ongoing LEXO® study aims to contribute to a further development of the current state-of-the-art procedure in robot-assisted rehabilitation in children with neurological disabilities. We are always thrilled to support researchers worldwide who are creating new evidence that deepens our understanding and knowledge of how technology can enhance clinical outcomes.

Read more about the current knowledge about robot-assisted rehabilitation in children: Castelli et al. 2022 https://doi.org/10.3233/nre-220036

Newsletter Anmeldung

Tyromotion GmbH - Headquarters

Bahnhofgürtel 59
8020 Graz, AUSTRIA
Phone: +43 316 908 909
Fax: +43 316 231123 9144
Mail: office@tyromotion.com

Tyromotion Inc - USA

1341 Capital Circle, SE
Suite J
Marietta, GA 30067, USA
Phone: + 1 678 903 8915
Fax: + 1 888 845 4494
Mail: usa@tyromotion.com

Tyromotion Contact Deutschland

Phone: +49 9721 533 53 90
Mail: deutschland@tyromotion.com

Tyromotion Contact Switzerland

Mail: schweiz@tyromotion.com

Website by Rubikon Werbeagentur GmbH

Appointment request

    We are happy to contact you to schedule a demo at your facility.


    Your contact information will be stored for the purpose of contacting you within the scope of this request. By submitting this form you agree to this use. Further information can be found in our privacy policy.